Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396448
Status:
TERMINATED
Last Update Posted:
2012-11-07
First Post:
2006-11-06
Brief Title:
Effect of 2-year Administration of CP-945598 on Weight Loss Efficacy and Safety
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A 2-Year Randomized Double-Blind Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of CP-945598 In The Treatment Of Obese Subjects
Status:
TERMINATED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
See termination reason in detailed description
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine the long-term weight loss and safety of CP-945598 in obese adults
Detailed Description:
The CP-945598 program was terminated on November 3 2008 due to changing regulatory perspectives on the riskbenefit profile of the CB1 class and likely new regulatory requirements for approval No safety issues were involved in the termination decision
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None